Stocks
Novavax, Inc.NVAX
NASDAQHealthcareBiotechnology$10.23-0.63%
A biotechnology company focused on developing protein-based vaccines using recombinant nanoparticle technology and proprietary adjuvants. Its lead products and pipeline target infectious diseases including COVID-19, influenza, and RSV, with revenue historically tied to government procurement and glo...
Market Cap: $1.7B52W Range: $5.01 – $11.97
Congressional Interest in Novavax, Inc. (NVAX)
2 members of Congress have disclosed 3 trades in Novavax, Inc. (NVAX), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
2
Buys
1
Sells
2
Who in Congress Is Trading NVAX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-01-06 | Kurt Schrader | sell | $1K – $15K |
| 2020-10-13 | Pat Roberts | sell | $1K – $15K |